Check how courts have cited this case. Use our free citator for the most current treatment.
No. 9456322
United States Court of Appeals for the Ninth Circuit
United States v. Myron Motley
No. 9456322 · Decided December 29, 2023
No. 9456322·Ninth Circuit · 2023·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
December 29, 2023
Citation
No. 9456322
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS DEC 29 2023
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
UNITED STATES OF AMERICA, No. 21-10296
Plaintiff-Appellee, D.C. Nos.
3:19-cr-00026-LRH-WGC-1
v. 3:19-cr-00026-LRH-WGC
MYRON MOTLEY,
MEMORANDUM*
Defendant-Appellant.
Appeal from the United States District Court
for the District of Nevada
Larry R. Hicks, District Judge, Presiding
Argued March 10, 2023
Submitted December 29, 2023
Las Vegas, Nevada
Before: GRABER, CLIFTON, and BENNETT, Circuit Judges.
Myron Motley appeals his conviction and sentence arising from his
involvement in a conspiracy to distribute oxycodone and hydrocodone.1 We have
*
This disposition is not appropriate for publication and is not precedent
except as provided by Ninth Circuit Rule 36-3.
1
In a concurrently filed opinion, we address Motley’s challenge to the district
court’s order declining to suppress evidence obtained from two tracking warrants
and determining that the wiretap warrant was necessary and was supported by
probable cause. We address his remaining arguments in this disposition.
jurisdiction under 28 U.S.C. § 1291 and 18 U.S.C. § 3742(a). We affirm Motley’s
conviction, affirm his sentence in part and vacate it in part, and remand for limited
resentencing consistent with this disposition.
1. Motley waived his Speedy Trial Act claim because he never moved to
dismiss before trial. See 18 U.S.C. § 3162(a)(2); United States v. Tanh Huu Lam,
251 F.3d 852, 860–61 (9th Cir.), as amended on denial of reh’g and reh’g en banc
sub nom. United States v. Lam, 262 F.3d 1033 (9th Cir. 2001).
We review Motley’s speedy trial claim under the Sixth Amendment for plain
error, as he raises it for the first time on appeal. See United States v. Sykes, 658
F.3d 1140, 1149 (9th Cir. 2011). “In assessing the merits of a claimed violation of
the Sixth Amendment speedy trial right, courts are to conduct a balancing test
involving four separate factors: the length of the delay, the reason for the delay, the
defendant’s assertion of his right, and prejudice to the defendant.” Tanh Huu Lam,
251 F.3d at 855.
On balance, the factors do not support the claim. Even assuming that the
government should bear the responsibility for the COVID-related delay, the
“focal” factor—reason for the delay—is neutral because Motley and his
codefendants were also responsible for a substantial amount of the two-year delay.
United States v. King, 483 F.3d 969, 976 (9th Cir. 2007). Further, the remaining
factors do not weigh heavily in favor of a violation. The two-year delay was not
2
excessive. See id. Motley did not consistently assert his speedy trial rights. See
id. Finally, Motley’s claim of prejudice is weak, as he provides only general
assertions that he experienced anxiety and concern from his incarceration during
the COVID-19 pandemic and fails to show that the delay prejudiced his defense.
2. Even assuming that de novo review applies, as Motley urges, his
Batson claim fails. See Batson v. Kentucky, 476 U.S. 79 (1986). Because the first
step of Batson’s three-step burden shifting framework is not at issue, we analyze
only the second and third steps. See Hernandez v. New York, 500 U.S. 352, 358–
59 (1991) (plurality opinion). As to the second step, the government offered race-
neutral reasons for striking the alternative juror: he was young (twenty-two) and
unemployed, and he lacked a significant work history. Moving to step three,
Motley fails to show purposeful discrimination. Given the juror’s characteristics,
the prosecutor reasonably could have believed that the juror lacked the maturity
and experience to serve responsibly on a jury. Nor did the prosecutor challenge
three other Latino or Hispanic jurors, and Motley’s comparative analysis fails to
show pretext. These circumstances bolster our conclusion that Motley has not
proved purposeful discrimination.2 See Palmer v. Estelle, 985 F.2d 456, 458 (9th
2
To the extent that Motley claims that the trial court found the government’s
reasons were pretextual, we disagree. At best, the transcript reflects that the court
thought that they were not Batson-prohibited reasons or may have questioned the
strength of the reasons.
3
Cir. 1993); United States v. Hernandez-Garcia, 44 F.4th 1157, 1167 (9th Cir.),
cert. denied, 143 S. Ct. 508 (2022).
3. The government argues that plain error review applies to Motley’s
sufficiency-of-the-evidence challenges because, after the close of all the evidence,
he failed to renew his motion for judgment of acquittal under Federal Rule of
Criminal Procedure 29. But even assuming that de novo review applies, as Motley
argues, his insufficiency-of-the-evidence challenges fail. A conviction must be
upheld if, “viewing the evidence in the light most favorable to the prosecution, any
rational trier of fact could have found the essential elements of the crime beyond a
reasonable doubt.” Jackson v. Virginia, 443 U.S. 307, 319 (1979).
Contrary to Motley’s position, the prosecution could prove the requisite
mens rea under 21 U.S.C. § 841(a)(1) by showing that Motley “knew the identity
of the substance[s] he possessed.” McFadden v. United States, 576 U.S. 186, 192
(2015). There was more than sufficient evidence supporting the mens rea element.
The doctor involved in the conspiracy, Dr. Math, wrote Motley many prescriptions
for oxycodone. Motley provided a coconspirator with a prescription for
hydrocodone written by Dr. Math and, after filling the prescription, the
coconspirator gave Motley the prescription bottle so that Motley could take his
share of the pills. The label on the bottle explained that the substance contained
“hydrocod/acetam,” short for hydrocodone and acetaminophen. Based on this
4
evidence, a rational juror could have found that Motley knew the substances were
oxycodone and hydrocodone.
We also reject Motley’s claim that the evidence was insufficient to prove a
conspiratorial agreement to possess with intent to distribute, or to distribute, the
controlled substances. Motley obtained monthly prescriptions for large amounts of
oxycodone or hydrocodone from Dr. Math in his own name and in his
coconspirators’ names. Motley paid Dr. Math between $600 and $800 for each
prescription, and Dr. Math knew that Motley and his coconspirators were selling
the pills and knew that he was vital to the conspiracy. During a recorded phone
call between Motley and a coconspirator, they discussed how many pills the
coconspirator had received, who should sell the pills, and the exchange of money.
Another coconspirator testified that Motley would take a portion of her pills to
resell. Viewing all this evidence in the government’s favor, a rational juror could
have found that Motley agreed with his coconspirators to possess with intent to
distribute or to distribute oxycodone and hydrocodone. See United States v.
Loveland, 825 F.3d 555, 557 (9th Cir. 2016) (noting that a conspiratorial
agreement can be proved by circumstantial evidence).
4. Motley’s jury instruction challenges are unavailing. Under
McFadden, the district court correctly refused to instruct the jury that the
government had to prove that Motley knew the substances were listed as controlled
5
substances. 576 U.S. at 192. A multiple conspiracies instruction was unnecessary
because Motley was the only defendant at trial, and so there was no risk of
spillover of guilt from a codefendant. See United States v. Liu, 631 F.3d 993, 1000
(9th Cir. 2011). The evidence also did not support a multiple conspiracies defense
because the evidence showed that Motley was a key participant in the charged
conspiracy, rather than a person involved only in a separate uncharged conspiracy.
See United States v. Moe, 781 F.3d 1120, 1127 (9th Cir. 2015). Finally, the court
instructed the jury that it had to find that “there was a plan to commit at least one
of the crimes alleged in the indictment as an object or purpose of the conspiracy
with all of you agreeing as to the particular crime which the conspirators agreed to
commit,” (emphasis added), and that Motley “joined in the agreement.” These
instructions amounted to a specific unanimity instruction, as they informed the jury
that it had to agree on which conspiracy supported the conspiracy conviction.
The indictment was not improperly amended by the jury instructions. “For a
constructive amendment to inhere, jury instructions must ‘diverge materially’ from
the indictment and evidence must have been ‘introduced at trial that would enable
the jury to convict the defendant for conduct with which he was not charged.’”
United States v. Alvarez-Ulloa, 784 F.3d 558, 570 (9th Cir. 2015) (quoting United
States v. Ward, 747 F.3d 1184, 1191 (9th Cir. 2014)). Although the instruction on
the conspiracy charge omitted the indictment’s text that the conspiracy was “not
6
for a legitimate medical purpose and not in the usual course of professional
practice,” the court gave, verbatim, a separate instruction proposed by Motley:
A person who works with or for a pharmacy or a physician may not be
convicted when he or she distributes or dispenses controlled substances
in good faith for a legitimate medical purpose and in the usual course
of professional practice.
A controlled substance is distributed or dispensed by a physician
or pharmacist in the usual course of his or her professional practice and,
therefore, lawfully, if the substance is distributed or dispensed by him
or her in good faith in medically treating a patient.
When you consider the good faith defense, it is the defendant’s
belief that is important. It is the sincerity of his belief that determines
if he acted in good faith.
If the defendant’s belief is unreasonable, you may consider that
in determining his sincerity of belief, but an unreasonable belief
sincerely held is good faith.
Considering this instruction, which tracks the relevant wording in the indictment,
the jury instructions did not “diverge materially” from the indictment. Id.
5. In sentencing Motley, the district court did not clearly err in finding
that Motley was an organizer or leader. See United States v. Avila, 95 F.3d 887,
889 (9th Cir. 1996). Considering all the evidence, the district court reasonably
concluded that Motley exercised control over or organized others, as he arranged
for, bought, and obtained his coconspirators’ prescriptions. See id. And after the
prescriptions were filled, Motley took or acquired large amounts of the pills so that
he could resell them.
7
6. Nothing in the record suggests that the district court failed to
appreciate its discretion to vary from the Sentencing Guidelines on policy grounds
under Kimbrough v. United States, 552 U.S. 85 (2007). Motley points to a single
statement made by the district court: “[T]he Court’s policy, of course, [is] to be
guided in every case by the sentencing guidelines.” But that statement accurately
describes the Guidelines’ purpose. See Beckles v. United States, 580 U.S. 256, 263
(2017) (“[The Guidelines] guide the exercise of a court’s discretion in choosing an
appropriate sentence within the statutory range.” (emphasis added)).
7. We reject Motley’s challenges to the district court’s total converted
drug weight calculation. Contrary to Motley’s argument, the district court did not
improperly shift the burden by requiring him to prove a weight calculation. The
record shows that the court found that the government had met its burden and then
simply permitted Motley to challenge the court’s finding.
Further, the court’s calculation was not clearly erroneous. See United States
v. Alvarez, 358 F.3d 1194, 1212 (9th Cir. 2004). Based on the evidence—
including that Dr. Math regularly delivered the coconspirators’ prescriptions to
Motley directly and that Motley paid Dr. Math for his coconspirators’
prescriptions—the court reasonably concluded that the government had proved by
a preponderance that all the pills prescribed by Dr. Math to Motley and his
coconspirators during the relevant period were within the scope and in furtherance
8
of the conspiracy and reasonably foreseeable. See id.; U.S. Sent’g Guidelines
Manual § 1B1.3(a)(1)(A)–(B) (U.S. Sent’g Comm’n 2018) [hereinafter U.S.S.G.].
8. The district court did not impose a substantively unreasonable
sentence. The record shows that the court considered the required factors under 18
U.S.C. § 3553(a) in a “rational and meaningful” manner. United States v. Ressam,
679 F.3d 1069, 1089 (9th Cir. 2012) (en banc) (quoting United States v. Tomko,
562 F.3d 558, 568 (3d Cir. 2009) (en banc)). Further, the sentence of 179 months
fell within the Guidelines range. See United States v. Carty, 520 F.3d 984, 988
(9th Cir. 2008) (en banc) (“[W]e recognize that a correctly calculated Guidelines
sentence will normally not be found unreasonable on appeal.”). Considering the
totality of the circumstances, the district court did not abuse its discretion by
imposing a substantively unreasonable sentence. See id. at 993.
9. The district court did not orally pronounce the discretionary
“standard” supervised release conditions set forth in U.S.S.G. § 5D1.3(c), but they
appear in the written judgment. Under our recent decision in United States v.
Montoya, 82 F.4th 640, 644–45 (9th Cir. 2023) (en banc), this was error. Thus, as
in Montoya, we vacate the conditions of supervised release that were referred to as
the “standard conditions” in the written judgment and remand “so that the district
court can cure its error by orally pronouncing any of the standard conditions of
supervised release that it chooses to impose and by giving [Motley] a chance to
9
object to them.” Id. at 656. Because the circumstances here are materially
indistinguishable from those in Montoya, see id. at 645, we reject Motley’s
contention that we should simply strike the standard conditions. See Dkt. No. 51.
10. The district court plainly erred by imposing Special Condition 2,
which improperly delegated to the probation officer the authority to decide whether
Motley must participate in outpatient substance abuse treatment. Like the error in
United States v. Nishida, the district court here delegated a decision that goes to the
“nature or extent” of the punishment imposed. 53 F.4th 1144, 1152–53 (9th Cir.
2022). Under Nishida, Motley has shown that he is entitled to plain-error relief.
See id. We therefore vacate Special Condition 2 and remand for the district court
to reconsider that condition. See Montoya, 82 F.4th at 656 (noting that we have
discretion whether to “vacate only a particular portion of the supervised release
sentence”).
CONVICTION AFFIRMED; SENTENCE AFFIRMED IN PART AND
VACATED IN PART; and REMANDED.
10
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS DEC 29 2023 MOLLY C.
Key Points
01NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS DEC 29 2023 MOLLY C.
02COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES OF AMERICA, No.
04Hicks, District Judge, Presiding Argued March 10, 2023 Submitted December 29, 2023 Las Vegas, Nevada Before: GRABER, CLIFTON, and BENNETT, Circuit Judges.
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS DEC 29 2023 MOLLY C.
FlawCheck shows no negative treatment for United States v. Myron Motley in the current circuit citation data.
This case was decided on December 29, 2023.
Use the citation No. 9456322 and verify it against the official reporter before filing.